文献
J-GLOBAL ID:201702254252654313
整理番号:17A1548739
抗精神病薬使用の国際的動向:16カ国,2005 2014における研究【Powered by NICT】
International trends in antipsychotic use: A study in 16 countries, 2005-2014
著者 (32件):
Halfdanarson Oskar
(Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland)
,
Zoeega Helga
(Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland)
,
Zoeega Helga
(Medicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia)
,
Aagaard Lise
(Life Science Team, Bech-Bruun Law Firm, Copenhagen, Denmark)
,
Bernardo Miquel
(Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, and Hospital Clinic, Department of Medicine, Barcelona University, and Institut d’Investigacions Biomediques August Pi I Sunyer (IDIBAPS), and Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Barcelona, Spain)
,
Brandt Lena
(Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden)
,
Fuste Anna Coma
(Pharmacy Department of Barcelona Health Region, Catalan Health Service (CatSalut), Barcelona, Spain)
,
Furu Kari
(Division of Mental and Physical Health, Norwegian Institute of Public Health, Norway)
,
Garuoliene Kristina
(Medicines Reimbursement Department, National Health Insurance Fund of the Republic of Lithuania, Vilnius, Lithuania, and Faculty of Medicine, Department of Pathology, Forensic Medicine and Pharmacology, Vilnius University, Lithuania)
,
Hoffmann Falk
(Department of Health Services Research, Carl von Ossietzky University Oldenburg, Germany)
,
Huybrechts Krista F.
(Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
,
Kalverdijk Luuk J.
(University of Groningen, University Medical Center Groningen, Department of Psychiatry, The Netherlands)
,
Kawakami Koji
(Department of Pharmacoepidemiology and Clinical Research Management, Graduate School of Medicine and Public Health, Kyoto University, Japan)
,
Kieler Helle
(Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden)
,
Kinoshita Takuya
(Department of Pharmacoepidemiology and Clinical Research Management, Graduate School of Medicine and Public Health, Kyoto University, Japan)
,
Litchfield Melisa
(Medicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia)
,
Lopez Soffy C.
(Grupo de Investigacion en Farmacoepidemiologia y Farmacovigilancia, Universidad Tecnologica de Pereira - Audifarma S.A., Pereira, Colombia)
,
Machado-Alba Jorge E.
(Grupo de Investigacion en Farmacoepidemiologia y Farmacovigilancia, Universidad Tecnologica de Pereira - Audifarma S.A., Pereira, Colombia)
,
Machado-Duque Manuel E.
(Grupo de Investigacion en Farmacoepidemiologia y Farmacovigilancia, Universidad Tecnologica de Pereira - Audifarma S.A., Pereira, Colombia)
,
Mahesri Mufaddal
(Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA)
,
Nishtala Prasad S.
(New Zealand’s National School of Pharmacy, University of Otago, Dunedin, New Zealand)
,
Pearson Sallie-Anne
(Medicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia)
,
Reutfors Johan
(Centre for Pharmacoepidemiology, Department of Medicine, Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden)
,
Saastamoinen Leena K.
(Kela Research, The Social Insurance Institution, Helsinki, Finland)
,
Sato Izumi
(Department of Pharmacoepidemiology and Clinical Research Management, Graduate School of Medicine and Public Health, Kyoto University, Japan)
,
Schuiling-Veninga Catharina C.M.
(Unit of Pharmacotherapy, -Epidemiology and -Economics, Department of Pharmacy, University of Groningen, The Netherlands)
,
Shyu Yu-Chiau
(Community Medicine Research Center, Chang Gung Memorial Hospital, Keelung, Taiwan, and Institute of Molecular Biology, Academia Sinica, Taipei, and Department of Nutrition, Chang Gung University of Science and Technology, Kwei-Shan, Taiwan)
,
Skurtveit Svetlana
(Division of Mental and Physical Health, Norwegian Institute of Public Health, Norway)
,
Verdoux Helene
(University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Team Pharmaco-epidemiology, UMR 1219, F33000 Bordeaux, France)
,
Wang Liang-Jen
(Department of Child & Adolescent Psychiatry, Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine, Kaohsiung, Taiwan)
,
Yahni Corinne Zara
(Pharmacy Department of Barcelona Health Region, Catalan Health Service (CatSalut), Barcelona, Spain)
,
Bachmann Christian J.
(Freelance Researcher, Marburg, Germany)
資料名:
European Neuropsychopharmacology
(European Neuropsychopharmacology)
巻:
27
号:
10
ページ:
1064-1076
発行年:
2017年
JST資料番号:
W3163A
ISSN:
0924-977X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)